Free Trial

ACADIA Pharmaceuticals (ACAD) News Today

ACADIA Pharmaceuticals logo
$22.19 +0.21 (+0.96%)
Closing price 04:00 PM Eastern
Extended Trading
$21.98 -0.21 (-0.92%)
As of 06:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ACAD Latest News

ACADIA Pharmaceuticals Inc. stock logo
55,133 Shares in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Bought by CTC Alternative Strategies Ltd.
CTC Alternative Strategies Ltd. acquired a new position in shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 55,133 shares of the biopharmaceutical compan
ACADIA Pharmaceuticals Inc. stock logo
Neo Ivy Capital Management Raises Stock Holdings in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)
Neo Ivy Capital Management boosted its stake in shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD - Free Report) by 1,551.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5
ACADIA Pharmaceuticals Inc. stock logo
Voloridge Investment Management LLC Decreases Position in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)
Voloridge Investment Management LLC lessened its position in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD - Free Report) by 44.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 725,508 shares of the biopharmaceutical c
ACADIA Pharmaceuticals Inc. stock logo
55,566 Shares in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Purchased by Alpine Global Management LLC
Alpine Global Management LLC acquired a new position in shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD - Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm acquired 55,566 shares of the biopharmaceutical company's stock, valued at appro
ACADIA Pharmaceuticals Inc. stock logo
JT Stratford LLC Invests $278,000 in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)
JT Stratford LLC purchased a new stake in shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 15,170 shares of the biopharmaceutical company's stock, value
ACADIA Pharmaceuticals Inc. stock logo
Nuveen Asset Management LLC Reduces Holdings in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)
Nuveen Asset Management LLC trimmed its position in shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD - Free Report) by 1.2% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,347,093 shares of the biopharmaceutical company's stock after s
ACADIA Pharmaceuticals Inc. stock logo
Bank of America Corp DE Raises Stock Holdings in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)
Bank of America Corp DE boosted its holdings in shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD - Free Report) by 41.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 680,853 shares of the biopharmaceuti
ACADIA Pharmaceuticals Inc. stock logo
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Stock Holdings Lifted by Two Sigma Investments LP
Two Sigma Investments LP grew its position in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD - Free Report) by 12.0% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,243,442 shares of the biopharmaceutical compa
ACADIA Pharmaceuticals Inc. stock logo
ACADIA Pharmaceuticals (NASDAQ:ACAD) Stock Price Up 3.5% After Analyst Upgrade
ACADIA Pharmaceuticals (NASDAQ:ACAD) Shares Up 3.5% Following Analyst Upgrade
ACADIA Pharmaceuticals Inc. stock logo
ACADIA Pharmaceuticals (NASDAQ:ACAD) Price Target Raised to $35.00 at Deutsche Bank Aktiengesellschaft
Deutsche Bank Aktiengesellschaft boosted their price target on ACADIA Pharmaceuticals to $35.00 and gave the company a "buy" rating in a report on Wednesday.
ACADIA Pharmaceuticals Inc. stock logo
What is HC Wainwright's Forecast for ACAD FY2027 Earnings?
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD - Free Report) - HC Wainwright lifted their FY2027 earnings per share estimates for ACADIA Pharmaceuticals in a note issued to investors on Monday, May 19th. HC Wainwright analyst A. Fein now anticipates that the biopharmaceutical company will post earning
ACADIA Pharmaceuticals Inc. stock logo
Two Sigma Advisers LP Buys 778,900 Shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)
Two Sigma Advisers LP grew its position in shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD - Free Report) by 160.8% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,263,200 shares of the biopharmaceutical company's stock after purchasing a
ACADIA Pharmaceuticals Inc. stock logo
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Shares Sold by Millennium Management LLC
Millennium Management LLC lessened its holdings in shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD - Free Report) by 45.5% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,118,361 shares of the biopharmaceutica
ACADIA Pharmaceuticals Inc. stock logo
Rafferty Asset Management LLC Trims Stake in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)
Rafferty Asset Management LLC reduced its position in shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD - Free Report) by 47.4% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 150,234 shares of the biopharmaceutical comp
ACADIA Pharmaceuticals Inc. stock logo
Needham & Company LLC Forecasts Strong Price Appreciation for ACADIA Pharmaceuticals (NASDAQ:ACAD) Stock
Needham & Company LLC raised their price objective on ACADIA Pharmaceuticals from $27.00 to $30.00 and gave the stock a "buy" rating in a research note on Monday.
ACADIA Pharmaceuticals Inc. stock logo
HC Wainwright Issues Positive Forecast for ACADIA Pharmaceuticals (NASDAQ:ACAD) Stock Price
HC Wainwright raised their price target on ACADIA Pharmaceuticals from $27.00 to $32.00 and gave the company a "buy" rating in a report on Monday.
ACADIA Pharmaceuticals Inc. stock logo
Virtus Investment Advisers Inc. Invests $722,000 in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)
Virtus Investment Advisers Inc. acquired a new position in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 39,370 shares of the biopharmaceutical company's stock, va
ACADIA Pharmaceuticals Inc. stock logo
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Position Increased by Stonepine Capital Management LLC
Stonepine Capital Management LLC grew its holdings in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD - Free Report) by 11.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 220,000 shares of the biopharmaceutical compa
ACADIA Pharmaceuticals Inc. stock logo
Point72 Hong Kong Ltd Purchases Shares of 24,054 ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)
Point72 Hong Kong Ltd purchased a new stake in shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 24,054 shares of the biopharmaceutical co
ACADIA Pharmaceuticals Inc. stock logo
Man Group plc Has $22.41 Million Stock Position in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)
Man Group plc lowered its stake in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD - Free Report) by 4.3% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,221,022 shares of the biopharmaceutical c
ACADIA Pharmaceuticals Inc. stock logo
Lazard Asset Management LLC Has $2.77 Million Holdings in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)
Lazard Asset Management LLC grew its stake in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD - Free Report) by 55.5% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 150,928 shares of the biopharmaceutical company's stock aft
ACADIA Pharmaceuticals Inc. stock logo
ACADIA Pharmaceuticals (NASDAQ:ACAD) Reaches New 12-Month High - Time to Buy?
ACADIA Pharmaceuticals (NASDAQ:ACAD) Sets New 1-Year High - What's Next?
ACADIA Pharmaceuticals Inc. stock logo
Gotham Asset Management LLC Acquires 34,240 Shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)
Gotham Asset Management LLC lifted its position in shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD - Free Report) by 95.8% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 69,966 shares of the
ACADIA Pharmaceuticals Inc. stock logo
Ameriprise Financial Inc. Purchases 120,996 Shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)
Ameriprise Financial Inc. boosted its position in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD - Free Report) by 15.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 884,870 shares of the biopharmaceutical company's st
ACADIA Pharmaceuticals Inc. stock logo
Sphera Funds Management LTD. Buys 36,000 Shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)
Sphera Funds Management LTD. increased its stake in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD - Free Report) by 14.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 288,539 shares of the biopharmaceutical company's stock
ACADIA Pharmaceuticals Inc. stock logo
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Shares Sold by RTW Investments LP
RTW Investments LP cut its stake in shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD - Free Report) by 36.5% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 8,705,501 shares of the biopharmaceutical company's stock after selling 5,002,005 shares during
ACADIA Pharmaceuticals Inc. stock logo
Point72 Asia Singapore Pte. Ltd. Makes New Investment in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)
Point72 Asia Singapore Pte. Ltd. purchased a new stake in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 16,974 shares of the biopha
ACADIA Pharmaceuticals Inc. stock logo
2,230,815 Shares in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Purchased by Point72 Asset Management L.P.
Point72 Asset Management L.P. purchased a new position in shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 2,230,815 shares of th
ACADIA Pharmaceuticals Inc. stock logo
Point72 Europe London LLP Takes Position in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)
Point72 Europe London LLP purchased a new stake in shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 173,155 shares of the biopharmaceutical comp
Get ACADIA Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for ACAD and its competitors with MarketBeat's FREE daily newsletter.

ACAD Media Mentions By Week

ACAD Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ACAD
News Sentiment

1.02

1.02

Average
Medical
News Sentiment

ACAD News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ACAD Articles
This Week

33

9

ACAD Articles
Average Week

Get ACADIA Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for ACAD and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:ACAD) was last updated on 5/27/2025 by MarketBeat.com Staff
From Our Partners